CLDX Celldex Therapeutics, Inc. - Common Stock

NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗
$41,97
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$20–$45
87% of range
Analystenbewertung
BUY
22 analysts
Kursziel
$58
+38% upside
P/E (TTM)
-10.8
ROE
-43.8%
Nettogewinnmarge
-16748.0%

CLDX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne

Kurs
$41.97
Marktkapitalisierung
$2.79B
P/E (TTM)
-10.8
EPS (TTM)
$-3.90
Umsatz (TTM)
$2M
Dividendenrendite
—
ROE
-43.8%
Verschuldungsgrad
—
52W-Spanne
$20 – $45

CLDX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen

10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends

Umsatz & Nettoergebnis $2M
10-point trend, -77.2%
2016-12-31 → 2025-12-31
EPS $-3.90
7-point trend, -11.1%
2019-12-31 → 2025-12-31
Freier Cashflow $-214M
10-point trend, -84.5%
2016-12-31 → 2025-12-31
Margen -16748.0%

Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?

Kennzahl
5-Jahres-Trend
CLDX
Peer-Median
P/E (TTM)
5-point trend, +70.4%
-10.8
—
P/S (TTM) (K/V (TTM))
5-point trend, +201.3%
1807.6
18.3
P/B (K/B)
5-point trend, -20.3%
5.3
3.3
Price / FCF (Kurs / FCF)
5-point trend, +70.9%
-13.1
—

Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC

Kennzahl
5-Jahres-Trend
CLDX
Peer-Median
Operating Margin (Betriebsgewinnmarge)
5-point trend, -1114.3%
-18599.8%
—
Net Profit Margin (Nettogewinnmarge)
-16748.0%
-180.4%
ROA
-37.6%
-36.2%
ROE
-43.8%
-43.7%
ROIC
5-point trend, -33.7%
-54.5%
—

Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke

Kennzahl
5-Jahres-Trend
CLDX
Peer-Median
Current Ratio (Liquiditätsgrad)
5-point trend, -57.8%
10.5
9.7
Quick Ratio
5-point trend, -58.8%
10.2
—

Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR

Kennzahl
5-Jahres-Trend
CLDX
Peer-Median
Revenue YoY (Umsatz YoY)
5-point trend, -66.8%
-78.0%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
5-point trend, -66.8%
-13.1%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
5-point trend, -66.8%
-26.9%
—

Kennzahlen pro Aktie EPS, Buchwert pro Aktie, Cashflow pro Aktie, Dividende pro Aktie

Kennzahl
5-Jahres-Trend
CLDX
Peer-Median
EPS (Diluted) (EPS (Verwässert))
5-point trend, -137.8%
$-3.90
—

Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag

Kennzahl
5-Jahres-Trend
CLDX
Peer-Median

CLDX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial

KAUF 22 Analysten
  • Starker Kauf 7 31,8%
  • Kauf 13 59,1%
  • Halten 2 9,1%
  • Verkauf 0 0,0%
  • Starker Verkauf 0 0,0%

12-Monats-Kursziel

15 Analysten · 2026-08-14
Median-Ziel $56.00 +33,4%
Mittelwert-Ziel $58.07 +38,4%

Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum

Durchschn. Überraschung
-0.03%
Zeitraum EPS Actual EPS est. Überraschung
30. Juni 2026 $-0.94 $-1.08 0.14%
31. März 2026 $-1.18 $-1.16 -0.02%
31. Dezember 2025 $-1.22 $-1.03 -0.19%
30. September 2025 $-1.01 $-0.92 -0.09%
30. Juni 2025 $-0.85 $-0.87 0.02%
31. März 2025 $-0.81 $-0.77 -0.04%

Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen

Ticker Marktkapitalisierung P/E Umsatz Vj. Nettomarge ROE Bruttogewinnmarge
CLDX $1.81B -7.0 -78.0% -16748.0% -43.8% —
GRAL $3.45B -7.7 17.2% -277.5% -16.7% —
IOVA $1.12B -2.5 60.6% -148.4% -56.0% —
ARQT $3.58B -223.4 91.3% -4.3% -9.8% —
IMNM $2.43B -8.8 -23.2% -3060.0% -47.0% —
IRON $3.01B -13.2 — — -31.3% —
BEAM $2.82B -34.2 120.0% -57.2% -7.0% —
NRIX $1.80B -5.8 53.9% -314.9% -53.6% —
SLS $577M -15.1 — — -55.4% —

Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow

Gewinn- und Verlustrechnung 14
Jährliche Gewinn- und Verlustrechnung-Daten für CLDX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, -56.9% $2M $7M $7M $2M $5M $7M $4M $10M $13M $7M $5M $4M
Cost of Revenue 10-point trend, -87.5% $200.0K $200.0K $300.0K $100.0K $100.0K $200.0K $100.0K $700.0K $700.0K $2M · ·
R&D Expense 12-point trend, +134.8% $245M $164M $118M $82M $53M $43M $43M $66M $96M $103M $100M $104M
SG&A Expense 12-point trend, +112.6% $44M $39M $31M $27M $20M $14M $15M $19M $25M $36M $34M $21M
Operating Expenses 12-point trend, +129.3% $289M $202M $161M $118M $76M $71M $59M $166M $134M $140M $135M $126M
Operating Income 12-point trend, -134.7% $-287M $-195M $-155M $-115M $-71M $-63M $-55M $-156M $-122M $-133M $-130M $-122M
Pretax Income 11-point trend, -103.4% $-259M $-158M $-141M $-112M $-71M $-61M $-51M $-152M $-117M $-129M $-127M ·
Income Tax 7-point trend, +100.0% $0 $0 $0 · $-227.0K $-1M · $-765.0K $-24M · · ·
Net Income 3-point trend, -83.0% $-259M $-158M $-141M · · · · · · · · ·
EPS (Basic) 7-point trend, -11.1% $-3.90 $-2.45 $-2.92 $-2.40 $-1.64 $-2.02 $-3.51 · · · · ·
EPS (Diluted) 7-point trend, -11.1% $-3.90 $-2.45 $-2.92 $-2.40 $-1.64 $-2.02 $-3.51 · · · · ·
Shares (Basic) 7-point trend, +457761.7% 66,422,000 64,395,000 48,449,000 46,888 42,870 29,640 14,507 · · · · ·
Shares (Diluted) 7-point trend, +457761.7% 66,422,000 64,395,000 48,449,000 46,888 42,870 29,640 14,507 · · · · ·
EBITDA 12-point trend, -136.6% $-284M $-192M $-152M $-112M $-68M $-59M $-50M $-153M $-117M $-130M $-127M $-120M
Bilanz 24
Jährliche Bilanz-Daten für CLDX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +3.0% $29M $28M $35M $29M $39M $44M $11M $24M $40M $42M $72M $28M
Short-term Investments 8-point trend, +602.5% $490M $697M $389M $276M $369M $151M $53M $70M · · · ·
Prepaid Expense 12-point trend, +300.5% $14M $21M $5M $12M $2M $2M $1M $2M $3M $4M $4M $4M
Current Assets 12-point trend, +160.8% $535M $747M $432M $318M $411M $198M $67M $99M $145M $196M $295M $205M
PP&E (Net) 12-point trend, -49.4% $5M $4M $4M $4M $4M $4M $4M $6M $10M $13M $11M $11M
PP&E (Gross) 12-point trend, +18.1% $29M $28M $26M $25M $25M $25M $32M $32M $34M $33M $29M $25M
Accum. Depreciation 12-point trend, +68.1% $24M $23M $22M $22M $21M $21M $28M $26M $24M $20M $17M $14M
Goodwill 4-point trend, +914.8% · · · · · · · · $91M $91M $9M $9M
Intangibles 12-point trend, +24.7% $27M $27M $27M $27M $27M $31M $49M $49M $68M $81M $21M $22M
Other Non-current Assets 12-point trend, +675.7% $13M $10M $107.0K $104.0K $104.0K $41.0K $41.0K $2M $2M $2M $1M $2M
Total Assets 12-point trend, +135.1% $583M $792M $466M $353M $445M $236M $123M $156M $316M $383M $338M $248M
Accounts Payable 12-point trend, -54.7% $1M $3M $3M $3M $1M $1M $1M $1M $2M $2M $2M $3M
Accrued Liabilities 12-point trend, +143.7% $47M $34M $22M $13M $12M $8M $6M $7M $19M $29M $24M $19M
Current Liabilities 12-point trend, +108.2% $51M $40M $31M $19M $17M $14M $12M $13M $28M $35M $30M $24M
Capital Leases 7-point trend, -54.2% $784.0K $2M $928.0K $3M $1M $2M $2M · · · · ·
Deferred Tax Flat — no change across 2 periods · · · · · · · · · · $5M $5M
Other Non-current Liabilities 12-point trend, -65.9% $4M $3M $4M $5M $7M $10M $16M $19M $52M $83M $17M $12M
Total Liabilities 12-point trend, +53.5% $56M $45M $36M $27M $25M $26M $29M $32M $79M $118M $47M $36M
Common Stock 12-point trend, -25.6% $67.0K $66.0K $56.0K $47.0K $47.0K $40.0K $17.0K $12.0K $9.0K $121.0K $99.0K $90.0K
Retained Earnings 12-point trend, -291.1% $-1.81B $-1.56B $-1.40B $-1.26B $-1.14B $-1.07B $-1.01B $-962M $-813M $-719M $-591M $-464M
AOCI 12-point trend, +40.0% $4M $3M $3M $1M $2M $3M $3M $3M $3M $3M $2M $3M
Stockholders' Equity 12-point trend, +149.1% $527M $747M $429M $326M $419M $209M $94M $124M $236M $265M $290M $212M
Liabilities + Equity 12-point trend, +135.1% $583M $792M $466M $353M $445M $236M $123M $156M $316M $383M $338M $248M
Shares Outstanding 12-point trend, -25.7% 66,549,442 66,374,549 55,883,377 47,200,695 46,730,198 39,603,771 16,972,077 11,957,635 9,234,693 120,516,654 98,685,595 89,592,779
Cashflow 13
Jährliche Cashflow-Daten für CLDX
Kennzahl Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, +41.5% $3M $3M $3M $3M $3M $4M $5M $4M $4M $3M $3M $2M
Stock-based Comp 12-point trend, +428.6% $36M $34M $24M $16M $9M $4M $5M $8M $12M $15M $13M $7M
Amort. of Intangibles 7-point trend, -100.0% · · · · · $0 $0 $224.0K $896.0K $997.0K $1M $1M
Other Non-cash $8M · · · · · · · · · · ·
Operating Cash Flow 12-point trend, -107.8% $-211M $-158M $-107M $-104M $-61M $-40M $-46M $-75M $-100M $-113M $-99M $-102M
CapEx 12-point trend, +40.7% $3M $2M $2M $2M $1M $2M $731.0K $813.0K $2M $3M $5M $2M
Investing Cash Flow 11-point trend, +516.6% $209M $-290M $-106M $90M $-216M $-98M $17M $30M $46M $69M $-50M ·
Stock Issued 9-point trend, +128.9% · $432M $216M · $270M $171M $16M $29M $51M $14M $189M ·
Net Stock Activity 9-point trend, +128.9% · $432M $216M · $270M $171M $16M $29M $51M $14M $189M ·
Financing Cash Flow 11-point trend, -98.8% $2M $441M $218M $4M $272M $171M $16M $29M $51M $14M $193M ·
Net Change in Cash 12-point trend, +100.4% $515.0K $-6M $5M $-10M $-5M $33M $-13M $-16M $-2M $-30M $44M $-141M
Taxes Paid Flat — no change across 3 periods $0 $0 $0 · · · · · · · · ·
Free Cash Flow 12-point trend, -106.5% $-214M $-160M $-109M $-106M $-62M $-42M $-47M $-76M $-102M $-116M $-104M $-103M
Rentabilität 7
Jährliche Rentabilität-Daten für CLDX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Operating Margin 11-point trend, -444.8% -18599.8% -2778.9% -2245.3% -4889.0% -1531.8% -854.1% -1540.2% · -953.7% -1958.7% -2363.9% -3414.1%
Net Margin -16748.0% · · · · · · · · · · ·
Pretax Margin 8-point trend, -1719.2% -16748.0% -2248.8% -2054.8% -4765.6% -1520.9% -821.6% -1424.0% · -920.6% · · ·
EBITDA Margin 11-point trend, -449.1% -18381.0% -2733.6% -2201.6% -4766.1% -1465.8% -801.1% -1404.2% · -919.0% -1913.1% -2309.2% -3347.5%
ROA -37.6% · · · · · · · · · · ·
ROE -43.8% · · · · · · · · · · ·
ROIC 5-point trend, -33.7% -54.5% · · · -16.9% -29.7% · -125.5% -40.8% · · ·
Liquidität & Solvenz 2
Jährliche Liquidität & Solvenz-Daten für CLDX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +25.3% 10.5 18.9 13.9 17.1 24.9 13.9 5.7 7.9 5.2 5.6 9.8 8.4
Quick Ratio 12-point trend, +788.9% 10.2 18.4 13.6 16.4 24.7 13.7 5.5 1.9 1.5 1.2 2.4 1.1
Effizienz 1
Jährliche Effizienz-Daten für CLDX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -81.8% 0.0 0.0 0.0 0.0 0.0 0.0 0.0 · 0.0 0.0 0.0 0.0
Pro Aktie 5
Jährliche Pro Aktie-Daten für CLDX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +235.3% $7.92 $11.25 $7.68 $6.91 $8.98 $5.29 $5.54 $10.38 $1.71 $2.20 $2.94 $2.36
Revenue / Share 5-point trend, -100.0% $0.02 $109.01 $142.07 $50.27 $108.49 · · · · · · ·
Cash Flow / Share 5-point trend, +99.8% $-3.18 $-2450.16 $-2214.51 $-2212.34 $-1420.78 · · · · · · ·
Cash / Share 12-point trend, +38.7% $0.43 $0.43 $0.62 $0.62 $0.84 $1.11 $0.66 $2.03 $0.29 $0.35 $0.73 $0.31
EPS (TTM) 7-point trend, -11.1% $-3.90 $-2.45 $-2.92 $-2.40 $-1.64 $-2.02 $-3.51 · · · · ·
Wachstumsraten 3
Jährliche Wachstumsraten-Daten für CLDX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -109.1% -78.0% 2.0% 192.0% -49.3% -37.3% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -433.7% -13.1% 14.7% -2.5% · · · · · · · · ·
Revenue CAGR 5Y -26.9% · · · · · · · · · · ·
Bewertung (TTM) 10
Jährliche Bewertung (TTM)-Daten für CLDX
Kennzahl Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, -56.9% $2M $7M $7M $2M $5M $7M $4M $10M $13M $7M $5M $4M
Net Income TTM 3-point trend, -83.0% $-259M $-158M $-141M · · · · · · · · ·
Market Cap 12-point trend, -92.6% $1.81B $1.68B $2.22B $2.10B $1.81B $694M $38M $36M $5.90B $6.40B $23.21B $24.53B
P/E 7-point trend, -996.2% -7.0 -10.3 -13.6 -18.6 -23.6 -8.7 -0.6 · · · · ·
P/S 12-point trend, -82.9% 1169.9 238.9 322.0 892.5 388.2 93.5 10.6 3.8 463.1 943.0 4235.6 6839.4
P/B 12-point trend, -97.0% 3.4 2.2 5.2 6.4 4.3 3.3 0.4 0.3 25.0 24.1 80.0 115.9
P / Tangible Book 6-point trend, -6.9% 3.6 2.3 5.5 7.0 4.6 3.9 · · · · · ·
P / Cash Flow 12-point trend, +96.5% -8.6 -10.6 -20.7 -20.3 -29.6 -17.2 -0.8 -0.5 -59.1 -56.6 -234.7 -241.5
P / FCF 12-point trend, +96.4% -8.5 -10.5 -20.3 -19.9 -29.0 -16.5 -0.8 -0.5 -58.0 -55.3 -223.7 -237.0
Earnings Yield 7-point trend, +90.9% -14.4% -9.7% -7.4% -5.4% -4.2% -11.5% -157.4% · · · · ·

Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre

Gewinn- und Verlustrechnung
2025-12-312024-12-312023-12-312022-12-312021-12-31
Umsatz $2M$7M$7M$2M$5M
Betriebsgewinnmarge % -18599.8%-2778.9%-2245.3%-4889.0%-1531.8%
Nettoergebnis $-259M$-158M$-141M——
Verwässerte EPS $-3.90$-2.45$-2.92$-2.40$-1.64
Bilanz
2025-12-312024-12-312023-12-312022-12-312021-12-31
Liquiditätsgrad 10.518.913.917.124.9
Quick Ratio 10.218.413.616.424.7
Cashflow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Freier Cashflow $-214M$-160M$-109M$-106M$-62M

Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten

📊

Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.

Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.

Institutionelle Eigentümer (13F) 278 Einreicher · $2.6B gesamt · Stand 30. Juni 2026

Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.

Institutionelle Aktivität — Q2 2026 vs. Vorquartal
Neue Positionen Geschlossene Positionen Erhöht Abgenommen Nettoveränderung der Aktien
62 (-4 vs. Vorquartal) 20 (+8 vs. Vorquartal) 99 (+31 vs. Vorquartal) 56 (+1 vs. Vorquartal) +11.0M

Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.

Institution Wert Aktien % der verfolgten 13F Typ
WELLINGTON MANAGEMENT GROUP LLP $312.415.309 8.396.004 12,07% Aktien
Kynam Capital Management, LP $198.065.407 5.322.908 7,65% Aktien
STATE STREET CORP $145.134.889 3.900.427 5,61% Aktien
VANGUARD CAPITAL MANAGEMENT LLC $128.926.362 3.464.831 4,98% Aktien
Deep Track Capital, LP $109.365.809 2.939.151 4,22% Aktien
VANGUARD GROUP INC $95.540.813 3.517.703 3,69% Aktien
FMR LLC $87.111.215 2.341.070 3,36% Aktien
Logos Global Management LP $78.141.000 2.100.000 3,02% Aktien
Eversept Partners, LP $66.454.865 1.785.941 2,57% Aktien
GEODE CAPITAL MANAGEMENT, LLC $64.373.504 1.729.584 2,49% Aktien
Commodore Capital LP $50.233.500 1.350.000 1,94% Aktien
Bellevue Group AG $44.652.000 1.200.000 1,72% Aktien
BAKER BROS. ADVISORS LP $44.004.955 1.182.611 1,70% Aktien
MILLENNIUM MANAGEMENT LLC $43.564.984 1.170.787 1,68% Aktien
AMERICAN CENTURY COMPANIES INC $38.787.594 1.042.395 1,50% Aktien
EVENTIDE ASSET MANAGEMENT, LLC $38.586.770 1.037.000 1,49% Aktien
NOVO HOLDINGS A/S $38.140.250 1.025.000 1,47% Aktien
DIMENSIONAL FUND ADVISORS LP $37.326.505 1.003.131 1,44% Aktien
Elmind Capital, LP $36.837.900 990.000 1,42% Aktien
Driehaus Capital Management LLC $36.817.137 989.442 1,42% Aktien
Fisher Asset Management, LLC $36.677.040 985.677 1,42% Aktien
Pictet Asset Management Holding SA $34.136.752 917.408 1,32% Aktien
Foresite Capital Management VI LLC $32.734.121 879.713 1,26% Aktien
VANGUARD PORTFOLIO MANAGEMENT LLC $32.132.175 863.536 1,24% Aktien
GOLDMAN SACHS GROUP INC $31.451.827 845.252 1,21% Aktien
Assenagon Asset Management S.A. $29.347.378 788.696 1,13% Aktien
Woodline Partners LP $26.077.884 700.830 1,01% Aktien
Affinity Asset Advisors, LLC $26.047.000 700.000 1,01% Aktien
Rock Springs Capital Management LP $26.015.223 699.146 1,00% Aktien
TWO SIGMA INVESTMENTS, LP $24.604.554 661.235 0,95% Aktien
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $24.408.048 655.954 0,94% Aktien
ALGERT GLOBAL LLC $24.105.978 647.836 0,93% Aktien
ADAR1 Capital Management, LLC $23.053.158 619.542 0,89% Aktien
PANAGORA ASSET MANAGEMENT INC $21.304.139 572.538 0,82% Aktien
VANGUARD FIDUCIARY TRUST CO $20.576.125 552.973 0,79% Aktien
5AM Venture Management, LLC $18.503.417 497.270 0,71% Aktien
FEDERATED HERMES, INC. $18.340.549 492.893 0,71% Aktien
Candriam S.C.A. $17.885.437 481.125 0,69% Aktien
Ikarian Capital, LLC $17.804.985 478.500 0,69% Aktien
BRAIDWELL LP $16.247.598 436.646 0,63% Aktien
Redmile Group, LLC $16.146.200 433.921 0,62% Aktien
CITIGROUP INC $14.891.144 400.192 0,58% Aktien
Palo Alto Investors LP $14.878.642 399.856 0,57% Aktien
TSP Capital Management Group, LLC $13.809.638 371.127 0,53% Aktien
PFM Health Sciences, LP $12.753.765 342.751 0,49% Aktien
KENNEDY CAPITAL MANAGEMENT LLC $12.738.025 342.328 0,49% Aktien
SEGALL BRYANT & HAMILL, LLC $12.513.388 336.291 0,48% Aktien
Tetragon Partners GP Ltd $10.807.310 290.441 0,42% Aktien
SUPERSTRING CAPITAL MANAGEMENT LP $10.700.963 287.583 0,41% Aktien
GordonMD Global Investments LP $10.408.381 279.720 0,40% Aktien
BANK OF AMERICA CORP /DE/ $9.518.951 255.817 0,37% Aktien
SummitTX Capital, L.P. $9.487.024 254.959 0,37% Aktien
SPHERA FUNDS MANAGEMENT LTD. $8.962.698 240.868 0,35% Aktien
Rosalind Advisors, Inc. $7.442.000 200.000 0,29% Aktien
Universal- Beteiligungs- und Servicegesellschaft mbH $7.285.273 195.788 0,28% Aktien
Corient Private Wealth LP $6.925.155 186.110 0,27% Aktien
Trexquant Investment LP $6.866.138 184.524 0,27% Aktien
Mirador Capital Partners LP $6.737.019 181.054 0,26% Aktien
STEMPOINT CAPITAL LP $6.638.711 178.412 0,26% Aktien
BlackRock, Inc. $6.469.963 173.877 0,25% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $6.422.446 172.600 0,25% Kaufoption
Cinctive Capital Management LP $5.419.153 145.637 0,21% Aktien
BOOTHBAY FUND MANAGEMENT, LLC $5.211.781 140.064 0,20% Aktien
FIRST TRUST ADVISORS LP $5.160.357 138.682 0,20% Aktien
Swiss National Bank $5.023.350 135.000 0,19% Aktien
MONTANOVA CAPITAL, LLC $4.513.461 121.297 0,17% Aktien
Connor, Clark & Lunn Investment Management Ltd. $4.481.126 120.428 0,17% Aktien
Point72 Asset Management, L.P. $4.361.645 117.217 0,17% Aktien
Ikarian Capital, LLC $4.241.940 114.000 0,16% Verkaufsoption
RHUMBLINE ADVISERS $3.905.662 104.963 0,15% Aktien
Propel Bio Management, LLC $3.858.491 103.695 0,15% Aktien
SUSQUEHANNA INTERNATIONAL GROUP, LLP $3.754.489 100.900 0,15% Verkaufsoption
Integral Health Asset Management, LLC $3.721.000 100.000 0,14% Aktien
DEUTSCHE BANK AG\ $3.601.705 96.794 0,14% Aktien
Odyssean, LLC $3.537.517 95.069 0,14% Aktien
Caption Management, LLC $3.348.900 90.000 0,13% Verkaufsoption
MANUFACTURERS LIFE INSURANCE COMPANY, THE $3.324.267 89.338 0,13% Aktien
HighVista Strategies LLC $3.235.930 86.964 0,12% Aktien
DIADEMA PARTNERS LP $3.200.060 86.000 0,12% Verkaufsoption
AXA Investment Managers S.A. $3.138.704 121.326 0,12% Aktien
Bank of New York Mellon Corp $3.020.782 81.182 0,12% Aktien
PDT Partners, LLC $3.010.252 80.899 0,12% Aktien
TD Asset Management Inc $2.951.720 79.326 0,11% Aktien
ALPS ADVISORS INC $2.945.730 79.165 0,11% Aktien
ALLIANCEBERNSTEIN L.P. $2.811.661 88.640 0,11% Aktien
XTX Topco Ltd $2.795.773 75.135 0,11% Aktien
Seven Fleet Capital Management LP $2.610.802 70.164 0,10% Aktien
Birchview Capital, LP $2.600.979 69.900 0,10% Aktien
Quantinno Capital Management LP $2.569.276 69.048 0,10% Aktien
DAFNA Capital Management LLC $2.549.555 68.518 0,10% Aktien
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $2.525.864 79.630 0,10% Aktien
Man Group plc $2.362.984 63.504 0,09% Aktien
Rafferty Asset Management, LLC $2.089.602 56.157 0,08% Aktien
Caption Management, LLC $2.072.597 55.700 0,08% Aktien
Simplify Asset Management Inc. $1.977.116 53.134 0,08% Aktien
DIADEMA PARTNERS LP $1.893.989 50.900 0,07% Kaufoption
Burkehill Global Management, LP $1.860.500 50.000 0,07% Aktien
SEVEN GRAND MANAGERS, LLC $1.860.500 50.000 0,07% Aktien
VANGUARD ASSET MANAGEMENT, Ltd $1.850.491 49.731 0,07% Aktien
MetLife Investment Management, LLC $1.694.060 45.527 0,07% Aktien

Unternehmensinsider 49 Insider · 19 Führungskräfte · 23 Direktoren

Insider Rolle Letzte Aktivität Gehaltene Aktien Käufe 12m Verkäufe 12m Netto 12m
Anthony S Marucci PRESIDENT & CEO 25. Juni 2026 A 27.231 0 0 $0
Una S Ryan President & CEO 7. März 2008 A 899.213 0 0 $0
Samuel Bates Martin SVP AND CFO 25. Juni 2026 A 24.378 0 0 $0
Avery W Catlin Sr. VP & CFO 2. September 2016 M 83.586 0 0 $0
Teri L Lawver SVP & Chief Commercial Officer 25. Juni 2026 A — 0 0 $0
Freddy A. Jimenez SVP & GENERAL COUNSEL 25. Juni 2026 A 430 0 0 $0
Margo Heath-Chiozzi SVP OF REGULATORY AFFAIRS 25. Juni 2026 A 11.247 0 0 $0
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. 25. Juni 2026 A 408 0 0 $0
Elizabeth Crowley SR. VP & CPDO 25. Juni 2026 A 4.726 0 0 $0
Diane C. Young SVP, CHIEF MEDICAL OFFICER 25. Juni 2026 A 2.115 0 0 $0
Tibor Keler EXECUTIVE VP & CSO 25. Juni 2026 A 7.357 0 0 $0
Ronald Pepin SR. VP & CBO 25. Juni 2026 A 20.097 0 0 $0
Richard M. Wright Sr. VP & CCO 17. Juni 2021 A 208 0 0 $0
Theresa Lavallee SVP, Reg.& Precision Medicine 14. Dezember 2016 A — 0 0 $0
Ronald C Newbold Sr. VP, Business Dev. 6. Januar 2009 A 5.868 0 0 $0
Henry C Marsh JR V.P. Research 7. März 2008 M — 0 0 $0
Ronald W Ellis Sr VP R&D 5. Januar 2007 A — 0 0 $0
Michael E Furlong Sr. Dir. Bus. Development 1. Juli 2005 L 1.500 0 0 $0
Alistair Wheeler V.P. Medical Affairs 2. Januar 2004 A — 0 0 $0
Denice Torres Direktor 25. Juni 2026 A — 0 0 $0
Rita Jain Direktor 25. Juni 2026 A — 0 0 $0
Garry Arthur Neil Direktor 25. Juni 2026 A — 0 0 $0
Cheryl Cohen Direktor 25. Juni 2026 A — 0 0 $0
Keith L Brownlie Direktor 25. Juni 2026 A 10.000 0 0 $0
Herbert J Conrad Direktor 25. Juni 2026 A 38.500 0 0 $0
James J Marino Direktor 25. Juni 2026 A 12.704 0 0 $0
Harry Penner JR Direktor 25. Juni 2026 A 41.916 0 0 $0
Karen Shoos Lipton Direktor 17. Juni 2021 A 41.833 0 0 $0
Gerald Mcmahon PhD Direktor 3. Dezember 2018 F 180.697 0 0 $0
Larry Ellberger Direktor 13. Juni 2018 A 73.500 0 0 $0
Richard Van Den Broek Direktor 8. Juni 2016 A 233.500 0 0 $0
Timothy M Shannon Direktor 4. Juni 2014 A 83.212 0 0 $0
Rajesh R Parekh Direktor 22. September 2010 A 2.000 0 0 $0
Charles R Schaller Direktor 9. September 2010 P 5.000 0 0 $0
Alf A Lindberg Direktor 24. Mai 2007 A — 0 0 $0
Francis R Cano Direktor 24. Mai 2007 A — 0 0 $0
Peter A Sears Direktor 24. Mai 2007 A 72.739 0 0 $0
Barrie J Ward Direktor 25. Mai 2006 A 367.915 0 0 $0
PDI INC Direktor 26. Mai 2005 A — 0 0 $0
Frederick W Kyle Direktor 13. Mai 2004 C 7.000 0 0 $0
MEDAREX INC 10%-Eigentümer 24. Juni 2009 S 2.960.848 0 0 $0
Lorantis Holdings LTD 10%-Eigentümer 7. April 2008 J 0 0 0 $0
Thomas Andrew Davis — 15. Juni 2017 A 1.011 0 0 $0
George Elston — 8. Juni 2016 A 28.500 0 0 $0
Taha Keilani — 7. März 2008 A 2.000 0 0 $0
Paula R Freeman — 7. März 2008 M 2.955 0 0 $0
Michael Timothy Cooke — 5. Januar 2007 A — 0 0 $0
Mary Nicholson — 3. Januar 2005 A 500 0 0 $0
Anthony Helstosky — 6. Januar 2004 C 6.000 0 0 $0

Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten

Aktivisten & 5%+-Eigentümer 2 Beteiligungen

Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.

Anmelder Eingereicht Beteiligung Status Zweck Einreichung
Medarex, Inc. I.R.S. Employer Identification Number ×3 Einreichungen 26. Juni 2009 — Erste Einreichung — SEC
Lorantis Holdings Limited ×2 Einreichungen 12. Mai 2008 — Erste Einreichung — SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF-Besitz Gehalten von 50 ETFs

Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.

Fonds Gewicht Anteile Stand Quelle
SBIO · ALPS ETF Trust 1,33% 68.615 NS 31. Mai 2026 N-PORT
BBC · ETFis Series Trust I 0,88% 10.032 NS 30. April 2026 N-PORT
LABU · Direxion Shares ETF Trust 0,44% 70.017 NS 30. April 2026 N-PORT
MMSC · First Trust Exchange-Traded Fund VI… 0,23% 3.856 NS 31. Mai 2026 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0,23% 73.629 NS 30. April 2026 N-PORT
NUSC · Nushares ETF Trust 0,16% 62.064 NS 30. April 2026 N-PORT
FFSM · FIDELITY COVINGTON TRUST 0,13% 51.835 NS 30. April 2026 N-PORT
FYX · First Trust Exchange-Traded AlphaDE… 0,12% 43.658 NS 30. April 2026 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,11% 24.795 NS 30. April 2026 N-PORT
RSSL · Global X Funds 0,08% 32.806 NS 30. April 2026 N-PORT
ITWO · ProShares Trust 0,06% 3.561 NS 31. Mai 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,05% 368.761 NS 31. Mai 2026 N-PORT
DFAS · Dimensional ETF Trust 0,05% 204.021 NS 30. April 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,05% 6.865 NS 30. April 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,04% 30.973 NS 30. April 2026 N-PORT
UWM · ProShares Trust 0,04% 2.786 NS 31. Mai 2026 N-PORT
URTY · ProShares Trust 0,03% 2.818 NS 31. Mai 2026 N-PORT
GSSC · Goldman Sachs ETF Trust 0,02% 6.539 NS 31. Mai 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,01% 2.668 NS 31. Mai 2026 N-PORT
HDG · ProShares Trust 0,01% 71 NS 31. Mai 2026 N-PORT
DCOR · Dimensional ETF Trust 0,01% 7.780 NS 30. April 2026 N-PORT
ONEQ · Fidelity Commonwealth Trust 0,01% 26.307 NS 31. Mai 2026 N-PORT
TILT · FlexShares Trust 0,01% 4.620 NS 30. April 2026 N-PORT
DXUV · Dimensional ETF Trust 0,01% 753 NS 30. April 2026 N-PORT
DFAC · Dimensional ETF Trust 0,01% 79.390 NS 30. April 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 15.559 NS 30. April 2026 N-PORT
DFSU · Dimensional ETF Trust 0,00% 2.758 NS 30. April 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,00% 45.244 NS 31. Mai 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 14.544 NS 30. April 2026 N-PORT
AVSC · AMERICAN CENTURY ETF TRUST 0,00% 500 NS 31. Mai 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,00% 636 NS 31. Mai 2026 N-PORT
VXF · VANGUARD INDEX FUNDS — — 15. Juli 2026 Täglich
VTI · VANGUARD INDEX FUNDS — — 15. Juli 2026 Täglich
VTWO · VANGUARD SCOTTSDALE FUNDS — — 15. Juli 2026 Täglich
VTWV · VANGUARD SCOTTSDALE FUNDS — — 15. Juli 2026 Täglich
VTWG · VANGUARD SCOTTSDALE FUNDS — — 15. Juli 2026 Täglich
VTHR · VANGUARD SCOTTSDALE FUNDS — — 15. Juli 2026 Täglich
ITOT · iShares Trust — — 5. August 2026 Täglich
IWV · iShares Trust — — 18. August 2026 Täglich
IWN · iShares Trust — — 17. August 2026 Täglich
IWO · iShares Trust — — 18. August 2026 Täglich
IWM · iShares Trust — — 18. August 2026 Täglich
PRFZ · Invesco Exchange-Traded Fund Trust — — 13. Juli 2026 Täglich
OMFS · Invesco Exchange-Traded Self-Indexe… — — 13. Juli 2026 Täglich
VHT · VANGUARD WORLD FUND — — 20. Juli 2026 Täglich
ISCB · iShares Trust — — 5. August 2026 Täglich
ISCV · iShares Trust — — 5. August 2026 Täglich
SMMV · iShares Trust — — 18. August 2026 Täglich
ESML · iShares Trust — — 14. August 2026 Täglich
WSML · iShares Trust — — 5. August 2026 Täglich